Thursday, 19 November 2015

MDP on Pharmacovigilance and Drug Monitoring

Innovations and increase in the number of drugs into the market resulted in rise of adverse drug events and drug related toxicities. With the utmost importance on patient safety and regulatory compliance, pharmaceutical firms must effectively monitor and detect adverse event reports and comply with all regulatory standards. Increased public scrutiny has been driving the focus on drug safety surveillance.


* To understand different aspects of Medical Safety and Pharmacovigilance in practive.
* To Understand issues regarding risks and benefits of drug use in humans including the cause, manifestation and consequences of adverse drug events (ADEs).
* To understand about detection and monitoring of the Adverse Drug Reaction.
* To Understand aspects for Pharmacovigilance compliance and monitoring.

For more detailed information please visits